Study identifier:D8111C00005
ClinicalTrials.gov identifier:NCT05135455
EudraCT identifier:N/A
CTIS identifier:N/A
VAXZEVRIA Intramuscular injection General use result study for the long-term safety of VAXZEVRIA
Prevention of infectious disease caused by SARS-CoV-2
N/A
No
-
All
467
Observational
n/a - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Aug 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|